GlaxoSmithKline Pharma reports consolidated net loss of Rs 55 crore

Revenue from operations rose to Rs 810 crore for the fourth quarter, compared with Rs 744 crore in the year-ago period, the pharmaceutical major said in a regulatory filing

from Companies https://ift.tt/esimVrN
via IFTTT